BioSilta
11 articles about BioSilta
-
BioSilta Acquires Worldwide Rights To CyDisCo Technology From University of Oulu To Produce Proteins With Multi-Industry Applications
4/6/2016
-
BioSilta Establishes Headquarters In Cambridgeshire, UK, And Strengthens Board And Senior Management Team
10/28/2014
-
BioSilta And Sigma-Aldrich Corporation Sign Global Distribution Agreement
10/14/2014
-
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round
6/11/2014
-
BioSilta Introduces EnPresso B Growth Systems for Bacterial Cultures
6/24/2013
-
BioSilta Release: EnPresso(R) Yeast Defined Tablet Enhances Protein Production Using EnBase(R) Technology
10/17/2011
-
BioSilta Release: EnBase(R) Flo Yeast Medium Provides a New Powerful Solution for Yeast Growth and Biotransformation
6/6/2011
-
BioSilta: The New EnPresso(TM) Tablet Enhances Protein Production
10/27/2010
-
KTH Royal Institute of Technology Stockholm Selects EnBase(R) from BioSilta to Enhance Its Screening Methods within the Human Protein Atlas Project
5/18/2010
-
EnBase(TM) Microbial Cell Culture Technology from BioSilta Has Been Selected by an EU Consortium for Use within a Fully Integrated Enzyme Engineering Platform
4/27/2009
-
Strategic Collaboration Between BRAIN AG and BioSilta to Co-Develop High Throughput Enzyme Expression and Discovery Technologies
4/28/2008